0001181431-12-055550.txt : 20121025
0001181431-12-055550.hdr.sgml : 20121025
20121025172135
ACCESSION NUMBER: 0001181431-12-055550
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121023
FILED AS OF DATE: 20121025
DATE AS OF CHANGE: 20121025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DEBBANE RAYMOND
CENTRAL INDEX KEY: 0001053890
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30111
FILM NUMBER: 121162322
MAIL ADDRESS:
STREET 1: C/O THE INVUS GROUP, LLC
STREET 2: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEXICON PHARMACEUTICALS, INC./DE
CENTRAL INDEX KEY: 0001062822
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 760474169
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8800 TECHNOLOGY FOREST PLACE
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
BUSINESS PHONE: 2818633000
MAIL ADDRESS:
STREET 1: 8800 TECHNOLOGY FOREST PLACE
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
FORMER COMPANY:
FORMER CONFORMED NAME: LEXICON GENETICS INC/TX
DATE OF NAME CHANGE: 20000126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ulys, L.L.C.
CENTRAL INDEX KEY: 0001340098
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30111
FILM NUMBER: 121162323
BUSINESS ADDRESS:
STREET 1: C/O THE INVUS GROUP, LLC
STREET 2: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-317-1717
MAIL ADDRESS:
STREET 1: C/O THE INVUS GROUP, LLC
STREET 2: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER NAME:
FORMER CONFORMED NAME: Ulys, LLC
DATE OF NAME CHANGE: 20050928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Invus, CV
CENTRAL INDEX KEY: 0001378005
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30111
FILM NUMBER: 121162324
BUSINESS ADDRESS:
STREET 1: C/O THE INVUS GROUP, LLC
STREET 2: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 371-1717
MAIL ADDRESS:
STREET 1: C/O THE INVUS GROUP, LLC
STREET 2: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
rrd358758.xml
FORM 4
X0306
4
2012-10-23
0
0001062822
LEXICON PHARMACEUTICALS, INC./DE
LXRX
0001378005
Invus, CV
MARTEN MEESWEG 25
ROTTERDAM
P7
3068AV
NETHERLANDS
1
0
1
0
0001340098
Ulys, L.L.C.
750 LEXINGTON AVENUE, 30TH FLOOR
NEW YORK
NY
10022
1
0
1
0
0001053890
DEBBANE RAYMOND
C/O ULYS, L.L.C.
750 LEXINGTON AVENUE, 30TH FLOOR
NEW YORK
NY
10022
1
0
1
0
Common Stock
2012-10-23
4
P
0
3000000
2.25
A
283154744
I
See Footnote
On October 23, 2012, Invus, L.P. agreed to purchase 3,000,000 shares of Issuer common stock from the underwriters in a public offering of Issuer common stock. The purchase closed on October 23, 2012.
247,818,843 of the reported shares of Issuer common stock are owned directly by Invus, L.P., 29,782,609 of the reported shares of Issuer common stock are owned directly by Invus C.V. and 5,553,292 of the reported shares of Issuer common stock are owned directly by Invus Public Equities, L.P. Invus Advisors, L.L.C. is the general partner of Invus, L.P., and Invus Public Equities Advisors, LLC is the general partner of Invus Public Equities, L.P. Artal International S.C.A. is the managing member of each of Invus Advisors, L.L.C. and Invus Public Equities Advisors, LLC. Artal International Management S.A. is the managing partner of Artal International S.C.A., which is a wholly owned subsidiary of Artal Group S.A., which is a wholly owned subsidiary of Westend S.A., which is a wholly owned subsidiary of Stichting Administratiekantoor Westend (the "Stichting"). (Continued in footnote 3)
Mr. Pascal Minne is the sole member of the board of the Stichting. Ulys, L.L.C. is the general partner of Invus C.V., and Mr. Raymond Debbane is the sole member of Ulys, L.L.C. Accordingly, each of the Reporting Persons may be deemed to be beneficial owners of some or all of the reported securities. Each of the Reporting Persons disclaims beneficial ownership of such securities, except to the extent of its or his pecuniary interest therein.
Form 4 (2 of 2).
This Form 4 is a continuation of the Form 4 filed on the date hereof by Artal International S.C.A., Invus, L.P., Invus Public Equities, L.P., Invus Advisors, L.L.C., Invus Public Equities Advisors, LLC, Artal International Management S.A., Artal Group S.A., Westend S.A., Stichting Administratiekantoor Westend and Mr. Minne with respect to the 3,000,000 shares of Issuer common stock purchased by Invus, L.P. Such Reporting Persons, together with Invus C.V., Ulys, L.L.C. and Mr. Debbane, are joint filers with respect to such transaction.
For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Persons may be deemed to be directors by deputization of the Issuer by virtue of Invus, L.P.'s right to designate certain members of the Issuer's board of directors pursuant to a stockholders' agreement between the Issuer and Invus, L.P.
INVUS C.V., By: ULYS, L.L.C., its general partner, By: /s/ Raymond Debbane, Name: Raymond Debbane, Title: President
2012-10-25
ULYS, L.L.C., By: /s/ Raymond Debbane, Name: Raymond Debbane, Title: President
2012-10-25
RAYMOND DEBBANE, /s/ Raymond Debbane
2012-10-25